- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00536003
Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor (4P)
June 5, 2012 updated by: begoña Martinez de Tejada, Begona Martinez de Tejada
Prevention of Preterm Delivery With Vaginal Progesterone in Women With Preterm Labor
The administration of vaginal progesterone, in addition to standard tocolysis, will decrease the risk of delivering prematurely and of recurrent preterm labor.
We also hypothesize that the reduction in preterm delivery will be associated with a decrease in infant mortality and morbidity.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The principal aim is to demonstrate that progesterone reduces preterm birth before 37 weeks of gestation.
Secondary aims are to show that progesterone 1) reduces preterm birth before 32 and before 34 weeks of gestation 2) reduces the number and duration of recurring episodes of preterm labor and 3) reduces infant mortality and morbidity.
Study Type
Interventional
Enrollment (Actual)
384
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alem 349, Ezeiza, Provincia de Buenos Aires
-
Buenos Aires, Alem 349, Ezeiza, Provincia de Buenos Aires, Argentina
- Hospital Interzonal Alberto Antranik Eurnekian
-
-
Av. Diaz Velez 5044, Cuidad Autónoma de Buenos Aires
-
Buenos Aires, Av. Diaz Velez 5044, Cuidad Autónoma de Buenos Aires, Argentina
- Hospital Carlos G. Durand
-
-
Av. E. Galván 4102, Ciudad Autónoma de Buenos Aires
-
Buenos Aires, Av. E. Galván 4102, Ciudad Autónoma de Buenos Aires, Argentina
- Instituto Universitario CEMIC
-
-
Av. Las Heras 2670, Cuidad Autónoma de Buenos Aires
-
Buenos Aires, Av. Las Heras 2670, Cuidad Autónoma de Buenos Aires, Argentina
- Hospital Bernardino Rivadavia
-
-
Av. Libertador 710, Moreno, Provincia de Buenos Aires
-
Buenos Aires, Av. Libertador 710, Moreno, Provincia de Buenos Aires, Argentina
- Hospital Mariano y Luciano de la Vega
-
-
Av. Mate de Luna 1555, Provincia de Tucumán
-
Buenos Aires, Av. Mate de Luna 1555, Provincia de Tucumán, Argentina
- Hospital Maternidad Nuestra Señora De Las Mercedes
-
-
Belgrano 1500, Villa Dolores, Provincia de Códoba
-
Buenos Aires, Belgrano 1500, Villa Dolores, Provincia de Códoba, Argentina
- Hospital Villa Dolores
-
-
Bvd. Pellegrini 3551, Provincia de Santa Fe
-
Buenos Aires, Bvd. Pellegrini 3551, Provincia de Santa Fe, Argentina
- Hospital J. B. Iturraspe
-
-
Casareto 118, Tigre, Provincia de Buenos Aires
-
Buenos Aires, Casareto 118, Tigre, Provincia de Buenos Aires, Argentina
- Hospital Comunal de Tigre
-
-
Diego Palma 505, San Isidro, Provincia de Buenos Aires
-
Buenos Aires, Diego Palma 505, San Isidro, Provincia de Buenos Aires, Argentina
- Hospital Materno Infantil de San Isidro
-
-
Dr. Félix Pagola 1502, Zárate, Provincia de Buenos Aires
-
Buenos Aires, Dr. Félix Pagola 1502, Zárate, Provincia de Buenos Aires, Argentina
- Hospital Virgen del Carmen
-
-
Dr. Juan Felipe Aranguren 2701, Cuidad Autónoma de B.A.
-
Buenos Aires, Dr. Juan Felipe Aranguren 2701, Cuidad Autónoma de B.A., Argentina
- Hospital Dr. T. Alvarez
-
-
Esteban De Luca 2151, Ciudad Autónoma de Buenos Aires
-
Buenos Aires, Esteban De Luca 2151, Ciudad Autónoma de Buenos Aires, Argentina
- Hospital Materno Infantil Ramon Sardá
-
-
Iparaguirre Nº 239, Pte. Derqui, Provincia de Buenos Aires
-
Buenos Aires, Iparaguirre Nº 239, Pte. Derqui, Provincia de Buenos Aires, Argentina
- Hospital Municipal Materno Infantil Comodoro Meisner
-
-
Juan D. Perón 4190, Ciudad Autónoma de Buenos Aires
-
Buenos Aires, Juan D. Perón 4190, Ciudad Autónoma de Buenos Aires, Argentina
- Hospital Italiano de Buenos Aires
-
-
La Paz 435, Provincia de Entre Ríos
-
Buenos Aires, La Paz 435, Provincia de Entre Ríos, Argentina
- Hospital Materno Infantil San Roque
-
-
Monte 848, Morón, Provincia de Buenos Aires
-
Buenos Aires, Monte 848, Morón, Provincia de Buenos Aires, Argentina
- Hospital Municipal Ostaciana B. de Lavignolle
-
-
Pedro Chutro 3380, Cuidad Autónoma de Buenos Aires
-
Buenos Aires, Pedro Chutro 3380, Cuidad Autónoma de Buenos Aires, Argentina
- Hospital J. M. Penna
-
-
Pilar 950, Ciudad Autónoma de Buenos Aires
-
Buenos Aires, Pilar 950, Ciudad Autónoma de Buenos Aires, Argentina
- Hospital Donación Francisco Santojanni
-
-
Py y Margall 750, Cuidad Autónoma de Buenos Aires
-
Buenos Aires, Py y Margall 750, Cuidad Autónoma de Buenos Aires, Argentina
- Hospital Dr. Cosme Argerich
-
-
Ramón Carillo 1339, Rafael Calzada, Provincia de Buenos Aires
-
Buenos Aires, Ramón Carillo 1339, Rafael Calzada, Provincia de Buenos Aires, Argentina
- Hospital Dr. Arturo Oñativia
-
-
Ricardo Balbín 1910, Merlo, Provincia de Buenos Aires
-
Buenos Aires, Ricardo Balbín 1910, Merlo, Provincia de Buenos Aires, Argentina
- Hospital Héroes de Malvinas
-
-
Rura 9 Constituyentes 395, Gral, Pacheco, Provincia de B.A.
-
Buenos Aires, Rura 9 Constituyentes 395, Gral, Pacheco, Provincia de B.A., Argentina
- Hospital Magdalena V. de Martínez
-
-
Ruta 8Km. 20,5 n°9100, Loma Hermosa, Provincia de Buenos Aires
-
Buenos Aires, Ruta 8Km. 20,5 n°9100, Loma Hermosa, Provincia de Buenos Aires, Argentina
- Hospital Dr. Carlos Bocalandro
-
-
-
-
-
Basel, Switzerland, 4031
- Universitäts-Frauenklinik Kantonespital Basel
-
Bern, Switzerland, 3010
- Universitätsfrauenklinik Bern
-
Chur, Switzerland, 7000
- Kantonales Frauenspital Chur
-
Geneva, Switzerland, 1211
- Maternity of the University Hospital of Geneva
-
Lausanne, Switzerland, 1011
- Centre Hospitalier Universitaire Vaudois
-
Luzern, Switzerland
- Frauenklinik Kantonspital Luzern
-
St Gallen, Switzerland, 9007
- Frauenklinik Kantonspital St Gallen
-
Winterthur, Switzerland, 8401
- Frauenklinik Kantonspital Winterthur
-
Zurich, Switzerland, 8091
- University Hospital Zurich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Gestational age between 240/7 et 336/7 weeks of gestation (based on a reliable estimate by ultrasound performed before 22 weeks)
- Singleton pregnancy
- Intact membranes
Preterm labor defined as:
- 2 or more regular and painful uterine contractions in 10 minutes plus one or plus of the following criteria:
- short cervix detected by vaginal ultrasound scanning (cervical length less than 30 mm until 31 weeks and less than 25 mm from 32 weeks)
- cervical changes detected clinically (cervical length less or equal 10 mm or Bishop score less than 6
- cervical changes during hospitalization (more or equal 5 mm between two clinical or US exams)
- positive fetal fibronectin
- Age ≥ 18 years old
- Signed informed consent
- Possible and accepted follow-up
Exclusion Criteria:
- Multiple gestation
- Cervical cerclage
- Hydramnios (AFI >95th percentile for gestational age or greatest pocket >8 cm)
- Premature rupture of membranes
- Chorioamnionitis (criteria for clinical diagnosis are: elevated WBC, elevated CRP, maternal tachycardia, fetal tachycardia, uterine tenderness and/or amniotic fluid foul odor)
- Cervical dilatation > 3 cm
- Placenta praevia or abruptio placentae
- Intra-uterine growth restriction or non-reassuring fetal status
- Pre-eclampsia or severe hypertension
- Any other maternal or fetal pathology which should indicate medically preterm delivery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
PLACEBO_COMPARATOR: 2
|
vaginal capsules containing placebo, once a day, until 36 6/7 weeks of gestation or until preterm delivery (whichever occurs first).
|
|
EXPERIMENTAL: 1
|
vaginal capsules containing 200 mg of natural progesterone, once a day, until 36 6/7 weeks of gestation or until preterm delivery (whichever occurs first).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The principal aim is to demonstrate that progesterone reduces preterm birth before 37 weeks of gestation
Time Frame: end of pregnancy
|
end of pregnancy
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Secondary aims are to show that progesterone 1) reduces preterm birth before 32 and before 34 weeks of gestation 2) reduces the number and duration of recurring episodes of preterm labor and 3) reduces perinatal mortality and morbidity, 4)Side effects
Time Frame: end of pregnancy and 28 days after delivery
|
end of pregnancy and 28 days after delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Begona Martinez de Tejada, MD, PhD, University Hospital, Geneva
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2006
Primary Completion (ANTICIPATED)
December 1, 2012
Study Completion (ANTICIPATED)
December 1, 2012
Study Registration Dates
First Submitted
September 24, 2007
First Submitted That Met QC Criteria
September 26, 2007
First Posted (ESTIMATE)
September 27, 2007
Study Record Updates
Last Update Posted (ESTIMATE)
June 6, 2012
Last Update Submitted That Met QC Criteria
June 5, 2012
Last Verified
June 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CER: 04-196
- matped 04-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Delivery
-
Istanbul University - Cerrahpasa (IUC)Kilis 7 Aralik UniversityCompletedPreterm Labor | Preterm Labor with Preterm Delivery in Third Trimester | Preterm Spontaneous Labor with Preterm DeliveryTurkey
-
Instituto de Investigacion Sanitaria La FeWithdrawn
-
University of Modena and Reggio EmiliaCompletedPreterm Labor With Preterm DeliveryItaly
-
Assistance Publique Hopitaux De MarseilleCompletedLow Risk of Preterm DeliveryFrance
-
University of Illinois at ChicagoTerminatedFocus: Prevent Preterm Delivery | Incidental Short Cervix at Mid-trimesterUnited States
-
Ain Shams UniversityRecruitingPreterm Labor With Preterm DeliveryEgypt
-
Ethem Unal, M.D., PhD, Associate Prof of Surgery...UnknownPreterm Birth | Preterm Labor | Preterm Labor Without Delivery | Side Effect of Drug | Preterm Labor With Preterm Delivery in Third Trimester | Calcium-Channel Blockers Toxicity
-
Konya Meram State HospitalRecruitingPregnancy Preterm | Preterm Labor Without DeliveryTurkey
-
University Hospital, Strasbourg, FranceRecruitingPreterm Delivery | Threatened Preterm LaborFrance
-
University of California, San FranciscoCompleted
Clinical Trials on progesterone
-
Hina MukhtarCompletedCervical Insufficiency | Preterm Labour | Pregnancy, High-RiskPakistan
-
Instituto Valenciano de Infertilidade de LisboaGedeon Richter Ltd.RecruitingInfertility | Natural Cycle | Artificial Cycle | Frozen Embryo Transfer (FET)Portugal
-
Brigham and Women's HospitalWithdrawnInfertilityUnited States
-
Aswan University HospitalUnknownTwin; Pregnancy, Affecting Fetus or NewbornEgypt
-
Medical University of South CarolinaNot yet recruitingPreeclampsia | Hypertensive Disorder of Pregnancy
-
Shady Grove Fertility Reproductive Science CenterFerring PharmaceuticalsCompleted
-
Universita di VeronaCompletedIn Vitro Fertilization | Progesterone | Luteal Phase SupportItaly
-
Assiut UniversityCompleted
-
Institut Universitari DexeusFundación Santiago Dexeus Font; Dexeus Clinic WomanCompletedInfertility | Frozen Embryo Transfer | Pregnancy Outcome | Progesterone | Euploid Embryo Transfer | Artificial Cycle | Ongoing PregnancySpain
-
University of British ColumbiaCompletedPerimenopause | Menstrual CrampsCanada